PUBLIC CONTRACT · 2019

Aquisição de BELIMUMAB 120MG E BELIMUMAB 400MG CONC SOL INJ FR IV

Contract value: €3,398.64
Signed on: 8 November 2019
Procedure: Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 6362677

PUBLISHED DESCRIPTION

51096019 - Aquisição de BELIMUMAB 120MG E BELIMUMAB 400MG CONC SOL INJ FR IV

Parties involved

Contracting body: Centro Hospitalar Universitário Lisboa Central, E. P. E.
Awardee: GLAXO SMITH KLINE-PROD. FARMACEUTICOS
Place of performance: Portugal, Lisboa, Lisboa
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: GLAXO SMITH KLINE-PROD. FARMACEUTICOS · Tax ID 500139962

Values and timeline

Contract price: €3,398.64
Procedure base price: €3,398.64
Total effective price: Not reported on Portal BASE
Publication date: 27 February 2020
Award date: 8 November 2019
Signing date: 8 November 2019
Performance period: 53 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion: Preço ou custo
CPV code: 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
Legal basis: Artigo 259.º do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement: CP 2017/6 - Acordo Quadro para fornecimento de Medicamentos do Foro Oncológico e Imunomoduladores, às Instituições e Serviços do Serviço Nacional de Saúde
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 4431072

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts